Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), sold 366,476 shares at $3.27 ($1.2M) on 2024-03-11, disclosed to the SEC on 2024-03-12.
Seasonal sale ($1.2M) by President and CEO — this insider has traded ALDX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.27 | 97,914 | $320K | 27.6% |
| 2 | $3.27 | 97,914 | $320K | 27.6% |
| 3 | $3.05 | 85,324 | $260K | 22.4% |
| 4 | $3.05 | 85,324 | $260K | 22.4% |
| Total | $3.17 avg | 366,476 | $1.2M | 100% |
| Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |
| ALDX | BUY | 2019-09-25 | $101K | — | Filing → |